Kate Middleton, the Princess of Wales, opened up about her experience with chemotherapy during a visit to a London hospital. ...

SGLT2 inhibitors are one of many medicines you may take to treat type 2 diabetes. They also can protect your kidneys and make heart failure less likely. (Photo Credit: Moment RF/Getty Images) SGLT2 ...

When canagliflozin (Invokana) was approved in 2013, the SGLT2 inhibitor was touted as a first in a new medication class that was, at the time, the only oral, once-daily medication to reduce blood ...

Adding an SGLT2 inhibitor to standard care did not improve clinical outcomes in critically ill patients with acute organ dysfunction, an open-label randomized trial involving intensive care units ...

Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes. Use of sodium-glucose cotransporter-2 (SGLT2) ...

Using SGLT2 inhibitors in the first-line treatment of type 2 diabetes lowered some cardiovascular risk, a claims database study showed. The combined 12-month risk for myocardial infarction (MI), ...

Please provide your email address to receive an email when new articles are posted on . Finerenone added to a SGLT2 inhibitor provided more CV and renal benefits than finerenone alone. Data were ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Combined use of an SGLT2 inhibitor and GLP-1 receptor ...

Genital mycotic infection is listed as a potential adverse effect of the SGLT2 inhibitor class. Strategies to prevent and manage sodium-glucose cotransporter 2 (SGLT2) inhibitor-associated genital ...